Ruggero Fariello
Corporate Officer/Principal at SeneXta Therapeutics SA
Profile
Ruggero Fariello is the founder of Newron Pharmaceuticals SpA, which was founded in 1999.
He held the title of Non-Executive Director from 1999 to 2007.
Dr. Fariello is currently a Member-Executive Board at SeneXta Therapeutics SA, starting in 2008.
Dr. Fariello has held former positions as Chairman & Professor at Rush University, Director-Research & Development at CNS, Inc. (Delaware), Director-Research & Development at Thomas Jefferson University, Senior Consultant at Pharmacia & Upjohn, Inc., and Chief Medical Officer at Neurotune AG.
Dr. Fariello obtained a doctorate degree from the University of Turin in 1965.
Ruggero Fariello active positions
| Companies | Position | Start |
|---|---|---|
SeneXta Therapeutics SA
 SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Corporate Officer/Principal | 2009-09-17 |
Former positions of Ruggero Fariello
| Companies | Position | End |
|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Founder | 2007-05-20 |
Neurotune AG
 Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Chief Tech/Sci/R&D Officer | 2013-02-19 |
| Thomas Jefferson University | Chief Tech/Sci/R&D Officer | - |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - |
CNS, Inc. (Delaware)
 CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN. | Chief Tech/Sci/R&D Officer | - |
Training of Ruggero Fariello
| University of Turin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
| Private companies | 4 |
|---|---|
SeneXta Therapeutics SA
SeneXta Therapeutics SA Medical SpecialtiesHealth Technology SeneXta Therapeutics SA engages in the research and development of therapies for neurodegenerative disorders. The firm provides medicines that maintain healthy brain ageing and rehabilitation after ischemic brain injury. The company was founded by Enrico Braglia and Federica Pericle in 2008 and is headquartered in Lugano, Switzerland. | Health Technology |
CNS, Inc. (Delaware)
CNS, Inc. (Delaware) Food RetailRetail Trade CNS, Inc. manufactures pharmaceutical products and health supplements. It markets the products as a treatment for allergies, snoring, and general nasal congestion. The company also sells FiberChoice, a chewable fiber supplement and a Breathe Right-branded throat rinse for snorers. It was founded in 1982 and is headquartered in Minneapolis, MN. | Retail Trade |
| Pharmacia & Upjohn, Inc. | Health Technology |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Ruggero Fariello
